Multiple Manufacturers

FLUDARABINE PHOSPHATE

Manufacturer:

Multiple Manufacturers

Fludarabine Phosphate HCPCS:

J9185

HCPCS Code Descriptor:

Injection, fludarabine phosphate, 50 mg

Category:

J Code

Fludarabine Phosphate NDCs:

59923-0604-02, 16729-0131-30, 63323-0196-06, 63323-0192-02, 25021-0242-02, 24201-0237-01, 45963-0621-51, 45963-0609-55

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

59923-0604-02, 63323-0196-06, 24201-0237-01, 45963-0621-51

About Fludarabine Phosphate:

FLUDARABINE PHOSPHATE is an Oncology drug manufactured by Sagent and administered via the Intravenous route of administration. The J Code: J9185 is aligned to the drug FLUDARABINE PHOSPHATE.

ACCESS PRICING AND MORE BY REGISTERING

J9185 Added Date:

January 1, 1994

J9185 Effective Date:

January 1, 2023

J9185 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fludarabine Phosphate billing and coding information.
Fludarabine Phosphate patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
FLUDARABINE PHOSPHATE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for FLUDARABINE PHOSPHATE. Please check back in a few weeks.